Why these 4 ASX shares have started the week with a bang

It has been a disappointing start to the week for the S&P/ASX 200 (Index: ^AXJO) (ASX: XJO). In afternoon trade the benchmark index is down 0.8% to 5,739 points due to heavy declines in the banking sector.

Despite this, four shares have managed to defy the market and make notably strong gains. Here’s why they have started the week strongly:

The Aconex Ltd (ASX: ACX) share price is up over 4% to $4.39 despite there being no news out of the software-as-a-service company. Short interest in the company’s shares has fallen in the last few months and currently sits at 12.9%. Although this is higher-than-average, it is a big drop from where it was at the end of last year. I believe this could be a sign that sentiment is shifting positively.

The MGC Pharmaceuticals Ltd (ASX: MXC) share price has rocketed 16% to 5 cents after the pot stock announced an agreement with the Biotechnical Faculty of the University of Ljubljana in Slovenia to begin a three-year comprehensive botanical research program. The two parties aim to develop medicinal cannabis strains tailored for specific medical indications which include epilepsy, chronic pain, and the side effects of oncology.

The Prima BioMed Limited (ASX: PRR) share price has surged higher by 19% to 3.7 cents. This morning the biotechnology company announced positive safety and efficacy data from the safety run-in stage of its clinical trial for IMP321 in metastatic breast cancer. Furthermore, the trial showed that IMP321 in combination with paclitaxel showed an encouraging disease control rate of 87%. Whilst it is early days, these are undoubtedly promising results.

The Vocus Group Ltd (ASX: VOC) share price has jumped 4% to $2.88 despite there being no news out of the growing telco company. But with its shares down 26% year-to-date, today’s gain could be a case of bargain hunters snapping up shares. Here’s why value investors might want to consider it as an investment today.

Missed out on gains today? Then don't miss out on these shares which I have tipped for big things in the future.

Top 3 ASX Blue Chips To Buy In 2017

For many, blue chip stocks means stability, profitability and regular dividends, often fully franked..

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool's in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool's Top 3 Blue Chip Stocks for 2017."

Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.

If you're expecting to see the likes of Commonwealth Bank, Telstra and Wesfarmers shares on this list, you'll be sorely disappointed. Not only are their dividends growing at a snail's pace, their profits are under pressure too due to the increasing competitive environment.

The contrast to these "new breed" blue chips couldn't be greater... especially the very real prospect of significant share price gains, something that's looking less likely from the usual blue chip suspects.

The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand - and how quickly the share prices of these companies moves - we may be forced to remove this report.

Click here to claim your free report.

Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia owns shares of ACONEX FPO and Vocus Communications Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.